Controlled Substances Need Tamper-Proof Controlled Release, Report Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Manufacturers should include safeguard plans against prescription drug abuse in NDA materials, according to a report from Columbia's Center on Addiction & Substance Abuse. The report finds a marked increase in prescription drug abuse and concludes that DTC advertising and internet availability are contributing to the rise.